WIRE — Allexer Namundjembo The Namibia Medicines Regulatory Council (NMRC) has confirmed that Fabu-Paracetamol meets required safety and quality standards following an independent assessment prompted by public concerns. In a public notice dated 20 May 2026, former Registrar of Medicines Fransina Nambahu said the NMRC commissioned independent laboratory testing on samples collected from various health facilities, including
"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."
This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.